Roche Holding AG (OTCMKTS:RHHBY) Stock Holdings Lifted by GAMMA Investing LLC

GAMMA Investing LLC lifted its position in Roche Holding AG (OTCMKTS:RHHBY - Free Report) by 6,463.8% during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 528,778 shares of the company's stock after buying an additional 520,722 shares during the period. GAMMA Investing LLC's holdings in Roche were worth $21,759,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently modified their holdings of the company. Boston Common Asset Management LLC lifted its stake in Roche by 10.0% during the first quarter. Boston Common Asset Management LLC now owns 325,732 shares of the company's stock valued at $13,369,000 after purchasing an additional 29,522 shares during the last quarter. Confluence Investment Management LLC increased its holdings in shares of Roche by 3.6% in the first quarter. Confluence Investment Management LLC now owns 14,491 shares of the company's stock valued at $596,000 after buying an additional 510 shares in the last quarter. Minot DeBlois Advisors LLC acquired a new stake in shares of Roche during the 4th quarter valued at $752,000. Hancock Whitney Corp lifted its position in shares of Roche by 6.8% during the 4th quarter. Hancock Whitney Corp now owns 23,516 shares of the company's stock valued at $820,000 after acquiring an additional 1,496 shares during the last quarter. Finally, HighPoint Advisor Group LLC boosted its stake in shares of Roche by 2.8% during the 4th quarter. HighPoint Advisor Group LLC now owns 11,091 shares of the company's stock worth $387,000 after acquiring an additional 304 shares in the last quarter.

Analyst Ratings Changes

A number of equities research analysts have recently issued reports on RHHBY shares. Hsbc Global Res lowered Roche from a "strong-buy" rating to a "hold" rating in a research report on Monday, April 28th. Morgan Stanley initiated coverage on Roche in a report on Wednesday, February 12th. They set an "equal weight" rating on the stock. UBS Group raised shares of Roche from a "hold" rating to a "strong-buy" rating in a research note on Thursday, February 13th. Finally, HSBC downgraded shares of Roche from a "buy" rating to a "hold" rating in a research report on Monday, April 28th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating, one has given a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat.com, Roche has a consensus rating of "Moderate Buy".

Roche Price Performance

Shares of RHHBY stock traded up $0.10 on Friday, reaching $40.86. 978,646 shares of the company's stock traded hands, compared to its average volume of 2,755,281. Roche Holding AG has a 12-month low of $33.30 and a 12-month high of $44.31. The company has a debt-to-equity ratio of 0.86, a quick ratio of 0.97 and a current ratio of 1.26. The business's 50 day moving average price is $39.14 and its two-hundred day moving average price is $38.83.

Roche Company Profile

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.